Seeking Alpha

Robbster

Robbster
Send Message
View Robbster's StockTalks BY TICKER:
  • Robbster
    Within my biotech portfolio, dip has created attractive prices on $PSTI $NBS $MDGN $SCTPF.
    7/12/14
    Reply
      • Robbster
        All my $STEM positions back in green now after couple years. +25% avg. Still long, great science, and better management of late.
        7/4/14
        Reply
          • Robbster
            Just jumped out of final bit of $NWBO at +100%. See local low coming, will be buyer again then. Still good science, wait for neg. to pass
            6/26/14
            Reply
              • Robbster
                Just hit 4x on my original $CUR position. Loving $STEM $NNVC rebounds. $BIND $OPXA $EDAP solid gains. Attractive SP $PSTI $SBOTF $MSTX
                6/25/14
                Reply
                  • Robbster
                    Couple more patience tests paying off in addition to $STEM: $EDAP $MDGN. Still waiting on $NBS & $PSTI. Loving new position in $BIND.
                    6/20/14
                    Reply
                      • Robbster
                        Ya know, I read AF activity as a manipulation gauge, don't pay attention to what he actually says. That would make me the foolish one :-)
                        6/20/14
                        Reply (1)
                        • Robbster: Still long $NWBO and up 121% since purchase...
                          6/20/14
                          • Robbster
                            Well well well, $STEM patience paying off at last. Other past recos on the move today: $TNXP $BIND $NNVC $CUR $NWBO. $OPXA attractive.
                            6/20/14
                            Reply (10)
                          • View all 10 replies
                            • Robbster: Decent entry price on $PSTI right now BTW...
                              6/21/14
                            • muldoon1959: Yes indeed, hence my interest right now. Thanks Robbster!
                              6/21/14
                              • Robbster
                                Still strong supporter of stem cell therapies: $CUR (#1), PSTI (#2), then $STEM $ATHX $NBS $SCTPF. $ATHX $STEM $SCTPF attractive PPS.
                                6/17/14
                                Reply (1)
                                • Tile: Why $BCLI is not on the list?
                                  6/27/14
                                  • Robbster
                                    Still strong on stem cell therapies. In order, $CUR (top tier) $PSTI (solid second) then $STEM $NBS $ATHX. $ATHX $STEM price attractive.
                                    6/17/14
                                    Reply
                                      • Robbster
                                        Growing novel delivery portion of portfolio of late, $BIND is an example. Reduced immuno plays to just $NWBO (which looks very good)
                                        6/16/14
                                        Reply (1)
                                        • Robbster: And a small retained position (20% of peak shares) in $IMUC, just in case they find a way to partner for subgroup GBM treatment.
                                          6/17/14
                                          • Robbster
                                            Just completed DD on $BIND, I'm in. Playing with house money now on $ONCS and $NWBO. $OPXA still attractive. Expecting even more from $CUR
                                            6/16/14
                                            Reply (1)
                                            • MIaffal33: Great move!
                                              6/17/14
                                              • Robbster
                                                Feel these will be looking at a strong year $OPXA $NWBO $CUR. Possibles include $ONCS $MSTX $PSTI
                                                6/14/14
                                                Reply
                                                  • Robbster
                                                    Reallocating most $IMUC holdings to stronger players. Will retain small position given efficacy in GBM subgroup. Increasing $NWBO again.
                                                    6/13/14
                                                    Reply
                                                      • Robbster
                                                        $NWBO's broader based approach to antigens is basis for favor vs. $IMUC. Stronger mechanism, stronger results.
                                                        6/13/14
                                                        Reply (1)
                                                        • longimgn: It appears U R correct in U'r assessment
                                                          6/14/14
                                                          • Robbster
                                                            Liking $MORL these days.
                                                            6/13/14
                                                            Reply
                                                              • Robbster
                                                                $ONCS pull back creates nice entry opportunity.
                                                                6/11/14
                                                                Reply
                                                                  • Robbster
                                                                    $MDGN starting to move, love their science and new management finally starting to have effect. Need more specifics on clinical pipeline...
                                                                    6/11/14
                                                                    Reply
                                                                      • Robbster
                                                                        We all need to think hard about $IMUC. As predicted, they have a promising GBM treatment for a SUB GROUP, great, issue is $ and time to ph3
                                                                        6/11/14
                                                                        Reply (3)
                                                                      • View all 3 replies
                                                                        • Lappy50: Still holding a bunch of $IMUC right now and I am underwater! Been in and out a lot in last 2-3 years!
                                                                          6/12/14
                                                                        • Robbster: Yes, me, too. Basically, I see stronger science in $NWBO approach. $IMUC will be limited to subgroup population.
                                                                          6/13/14
                                                                          • Robbster
                                                                            Getting close to 2x pps on my $NWBO position again, nice initial gains on $OPXA, still good entry point. $TNXP back to double digit gains.
                                                                            6/11/14
                                                                            Reply
                                                                              • Robbster
                                                                                +11% since purchase of $OPXA 4 weeks ago, still like this move, very sound science, management looks good, reasonable cash on hand.
                                                                                6/7/14
                                                                                Reply